MEDIUM confidence: 91% data completeness, but the composite (35) sits in the indecisive 30–70 range — strong-buy and short calls require a more decisive composite. What does confidence mean?
Technical context for active traders — derived from price, the 50/200-day moving averages, the 52-week range, and recent volume. Not part of the QScore.
AI classification of policy/regulatory sensitivity from the company's sector, industry, and business description. Exposure/sensitivity only — not a political opinion, a prediction of government action, or investment advice. As of 2026-07-10.
Dated events from the market calendar; the “also watch” items are AI-generated observations from QScoring data. Informational only — not investment advice, and dates can change.
Not enough return history to estimate factor exposures — 1 of 36 months required. This stock is too recently listed (or has too short a price history) for a reliable Fama-French regression.
Avg target $294 (last qtr, 14 analysts) → $306 (last mo, 3) (+4.2%).
Buy-rated share 91% → 91% over ~3 months (+0pp).
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Aug 2026 | $-0.17 | $-0.04 | +76.7% |
| Jun 2026 | $-0.16 | $-0.04 | +75.6% |
Net insider -$15.2M over 180 days (0 open-market buys, 88 sells). Insider buying is the informative signal; routine selling is normal.
Short interest, days-to-cover, and institutional-ownership change require a data-plan upgrade (not yet available).
Forward-return IC, quintile spread & hit rate publish on /performance as the tracking panel accrues enough no-look-ahead history.
Net buyback (repurchases less issuance) ÷ market cap, plus trailing dividend yield.
| Metric (USD) | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| Revenue | $25M— | $79M+219.9% | $290M+268.6% | $510M+75.7% |
| EPS (dil.) | $-0.83— | $-0.59n/m | $-2.25n/m | $0.41n/m |
| Free Cash Flow | -$175M— | -$86Mn/m | $429Mn/m | -$393M-191.7% |
| Gross Margin | 11.7% | 33.5%+21.7pp | 42.3%+8.8pp | 39.0%-3.3pp |
| Operating Margin | -726.4% | -170.1%+556.3pp | -35.0%+135.1pp | -28.5%+6.5pp |
| Net Margin | -721.9% | -161.5%+560.4pp | -165.9%-4.4pp | 46.6%+212.6pp |
Absolute figures with year-over-year change. Margins show the level with the change in percentage points (pp). “n/m” = not meaningful (prior ≤ 0); ⚠ marks a large percentage off a small base — read the dollar figure.
The QScore of 35 for CBRS indicates a relatively weak overall assessment, driven down by low scores in Value and Risk, as well as a subpar Profitability score. The stock scores high on Growth, with notable revenue and EPS growth of 75.7% and 118.2%, respectively. However, it trades at a significant premium, with a P/S ratio of 75.2 and negative EV/EBITDA, contributing to its low Value score. The long-term and short-term scores diverge, with the short-term score being 9 points higher, suggesting some near-term momentum, but overall the stock exhibits high volatility and risk.